
Can Occidental Sustain and Increase its Dividend Amid Energy Cycles?
Occidental's strong free cash flow is underpinned by its low-cost, high-margin operations in the Permian Basin, complemented by steady contributions from international assets. This solid operational performance supports the company's dual focus on reducing debt and enhancing shareholder returns. In 2024, Occidental increased its dividend by 22%, underscoring management's commitment to delivering sustainable and disciplined capital returns.
The company's diversified asset base, including its OxyChem segment and carbon capture ventures, adds resilience and optionality to earnings. These segments provide non-cyclical cash flows and position Occidental as a potential long-term energy transition player. Occidental's capital allocation strategy prioritizes returning excess free cash to its shareholders, with dividends forming a core component alongside buybacks.
The company's enhanced financial position, operational efficiency and broad-based cash flow streams provide a strong foundation for maintaining and gradually increasing its dividend over time. Although exposure to commodity price fluctuations introduces an element of risk, Occidental's strategic discipline and capital prudence reinforce the credibility of its dividend growth outlook and offer investors confidence in the sustainability of the dividend policy.
How Oil & Gas Companies Are Raising Shareholders' Value?
Oil and gas companies are enhancing shareholder value by consistently paying dividends, supported by strong cash flows and disciplined capital spending. These regular payouts reflect financial stability.
Some leading upstream oil and gas companies are ConocoPhillips COP and EOG Resources EOG, which are raising shareholder value through regular dividend payments.
ConocoPhillips returned a total of $9.1 billion to shareholders in 2024, including $5.5 billion through share repurchases and $3.6 billion through dividends.
EOG Resources has a track record of stable and growing dividends spanning 27 years. EOG has never suspended or lowered its dividend, even during business turmoil, reflecting a solid underlying business.
OXY Stock's Earnings Surprise History
The stable performance of the company allowed its earnings to beat estimates in each of the last four reported quarters, the average surprise being 24.34%.
Occidental's ROIC Lower Than the Industry
Occidental's return on invested capital ("ROIC") is lower than the industry average in the trailing 12 months. ROIC of OXY was 6.26% compared with the industry average of 6.61%.
OXY's Price Performance
Occidental's shares have gained 8.4% in the last three months compared with the Zacks Oil and Gas-Integrated-United States industry's rise of 8%.
Price Performance (Three months)
OXY's Zacks Rank
Occidental currently has a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
ConocoPhillips (COP): Free Stock Analysis Report
Occidental Petroleum Corporation (OXY): Free Stock Analysis Report
EOG Resources, Inc. (EOG): Free Stock Analysis Report
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
11 minutes ago
- Globe and Mail
PERFORMANT HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Performant Healthcare, Inc.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Performant Healthcare, Inc. (NasdaqGS: PHLT) to Machinify. Under the terms of the proposed transaction, shareholders of Performant will receive $7.75 in cash for each share of Performant that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit


Globe and Mail
11 minutes ago
- Globe and Mail
STAR EQUITY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Star Equity Holdings, Inc.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Star Equity Holdings, Inc. (NasdaqGM: STRR) to Hudson Global, Inc. (NasdaqGS: HSON). Under the terms of the proposed transaction, upon completion Star shareholders will own approximately 21% of the combined company. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit


Globe and Mail
11 minutes ago
- Globe and Mail
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc.
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed merger of Titan Pharmaceuticals, Inc. (the 'Company') (NasdaqCM: TTNP) and KE Sdn. Bhd. Under the terms of the proposed transaction, shareholders of Titan are expected to own approximately 13.3% of the combined company. KSF is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to the Company's shareholders. If you would like to discuss your legal rights regarding the proposed transaction, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit